Wednesday, 16 August 2017

Australia News

  • Johnson & Johnson in innovation collaboration with the Queensland Government

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2015

    Singapore: The Queensland Government has announced a collaboration with the US pharmaceutical and healthcare giant, Johnson & Johnson, to develop and commercialise healthcare innovation...Read more

  • APAC multiple myeloma market to value $2.8 bn by 2021: Report

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015

    Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from USD1.7 billion in 2014 to USD2.8 ...Read more

  • Aussie anesthetic firm gets patent from 7 nations

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013

    Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in the UK, Australia, New Zealand, Hong Kong, Singapore and South Africa....Read more

  • Inex iGeneScreen Prenatal Test hits Australia

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013

    Singapore: Singapore's Inex Innovations Exchange, a fetal health diagnostics company, signed a distribution agreement for iGeneScreen Prenatal Test in Australia with Primary Health Care (PH...Read more

  • Mr Mario Pennisi, LifeScience Queensland: Aus govt will provide stimulus amidst slow economy

    Australia |  Opinion | By BioSpectrum Bureau | 0 Comment | 25 Dec, 2012

    There is no doubt that the world is still in a delicate financial balance, with no significant chance of that improving in 2013. This overall situation, combined with the continued strength...Read more

  • Lignol to invest $1 mn in largest Aus biodiesel plant

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013

    Singapore: Lignol Energy, a leading technology company in the advanced biofuels and renewable chemicals sectors, will invest up to $1 million in Territory Biofuels Limited (TBF), which is t...Read more

  • Nohla Therapeutics raises $21mn

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Dec, 2015

    Singapore: Nohla Therapeutics, a developer of cellular therapies for haematological disorders and immunological diseases, has raised over $21 million from several institutional investors. ...Read more

  • Australia's TransBio, DendroCyte to develop antibody for transplant rejection

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2015

    Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and develop novel antibody therapeutics directed against CD83, a relative...Read more

  • New technologies push growth of Cochlear

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2012

    Innovation, passion and expertise have brought recognition to Cochlear for its niche focus on hearing aids medical devices. By now, around 250,000 people in over 100 countries are living be...Read more

  • Australian body launches research translation initiative

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012

    Singapore: Australia's body for supporting health and medical research National Health and Medical Research Council (NHMRC) has launched Research Translation Faculty for health and medical ...Read more

  • CSL marks a billion dollar in profits

    Australia |  Analysis | By Amrita Tejasvi | 0 Comment | 31 May, 2013

    One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1...Read more

  • Pharmaxis, NovaQuest enter $40 mn agreement

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013

    Singapore: Pharmaceutical company Pharmaxis announced the signing of a financing agreement with NovaQuest Pharma Opportunities Fund III, under which NovaQuest will invest up to $40 million...Read more

  • Innate Immunotherapeutics completes $9mn IPO

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013

    Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that the company would channelize to commence planning its clinical trial...Read more

  • BioDiem gets hepatitis vaccine tech from Canberra univ

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • NZ gets drug that glows brain tumour

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2015

    Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove malignant brain tumours has been approved for marketing and distribution ...Read more

  • Australia's Alchemia announces sale of Fondaparinux IP

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015

    Singapore: Alchemia, an Australian drug discovery and development company, has announced that it has entered into a binding term sheet for the sale of the worldwide exclusive intellectual p...Read more

  • UBI quarterly service fees increase by 311%

    Australia |  Company results | By BioSpectrum Bureau | 0 Comment | 25 Jan, 2013

    Singapore: Medical diagnostics company Universal Biosensors (UBI) published its quarterly cash flow report for the quarter ending December 31, 2012. The report highlighted strong revenue g...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls